Logo
I

Intravacc

63 employees

Even the most promising vaccines don’t always make it out of the laboratory into large-scale production. We at Intravacc are fully aware of the challenges on the long road of vaccine development. We substantially reduce the risks and costs involved with developing vaccines. How? By bridging the gap between your concept and late stage clinical studies. As an established independent CDMO in the vaccine industry, Intravacc offers a wide range of expertise and is the bridge between your discovery and the start of your phase I/II clinical trials in humans. Part of Utrecht Science Park Bilthoven

Investor insights

Funding rounds participated in

$633K sweet spot round size

Investor type

Privately Held

Basic info

Industry

Biotechnology Research

Sectors

Biotechnology Research

Date founded

2013

Funding rounds raised

Total raised

$633K

from 1 investors over 1 rounds

I

Intravacc raised $633K on February 11, 2024

Investors: CARB-X

FAQ